Granulocyte-macrophage-colony-stimulating factor: a review from preclinical development to clinical application

Transfusion. 1993 Jan;33(1):70-83. doi: 10.1046/j.1537-2995.1993.33193142315.x.
No abstract available

Publication types

  • Review

MeSH terms

  • Acquired Immunodeficiency Syndrome / therapy
  • Animals
  • Antineoplastic Agents / adverse effects*
  • Bone Marrow Transplantation*
  • Breast Neoplasms / surgery
  • Clinical Trials as Topic
  • Female
  • Granulocyte-Macrophage Colony-Stimulating Factor / pharmacokinetics
  • Granulocyte-Macrophage Colony-Stimulating Factor / pharmacology*
  • Granulocyte-Macrophage Colony-Stimulating Factor / therapeutic use*
  • Humans
  • Leukemia, Myeloid, Acute / surgery
  • Lymphoma / surgery
  • Myelodysplastic Syndromes / therapy
  • Neutropenia / chemically induced
  • Neutropenia / therapy*
  • Recombinant Proteins / pharmacokinetics
  • Recombinant Proteins / pharmacology
  • Recombinant Proteins / therapeutic use

Substances

  • Antineoplastic Agents
  • Recombinant Proteins
  • Granulocyte-Macrophage Colony-Stimulating Factor